PharmaTell seminar: Nanostructured lipid carriers for ocular drug delivery: ex vivo and in vivo efficacy and Fabricating hybrid conducting polymer / liquid crystal materials Event as iCalendar

08 April 2013

12 - 1pm

Venue: Room 505-364, Building 505, 85 Park Road, Grafton

Nanostructured Lipid Carriers for Ocular Drug Delivery: Ex Vivo and In Vivo Efficacy

After decades of research and investigation, Herpes keratitis ocular infection remains the leading cause of infectious blindness in the developed world and there is a need for a novel drug delivery system to improve the treatment options. In this study, Nanostructured lipid carriers (NLCs), were designed and developed for the ocular dug delivery of the antiviral drug Acyclovir (ACV) and their ex vivo and in vivo efficacy was examined.


Ali Seyfoddin, PhD candidate

Fabricating Hybrid Conducting Polymer / Liquid Crystal Materials

Controlled release drug delivery systems offer significant benefits in pharmacotherapy. However, to date, drug release rates cannot be modified after administration to the patient. This project aims to fabricate a system where an electrical stimulus results in phase transition in a liquid crystal leading to triggered drug release.


Katharina Lange, Visiting Intern